This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CalAmp (CAMP) Q4 Earnings Top Estimates
by Zacks Equity Research
CalAmp (CAMP) delivered earnings and revenue surprises of 12.00% and -5.16%, respectively, for the quarter ended February 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: CalAmp (CAMP) Q4 Earnings Expected to Decline
by Zacks Equity Research
CalAmp (CAMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OSI (OSIS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
OSI (OSIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CAMP or BWXT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CAMP vs. BWXT: Which Stock Is the Better Value Option?
What Makes CalAmp (CAMP) a Strong Sell?
by Zacks Equity Research
CalAmp (CAMP) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
New Strong Sell Stocks for December 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
CalAmp (CAMP) Tops Q3 Earnings Estimates
by Zacks Equity Research
CalAmp (CAMP) delivered earnings and revenue surprises of 4.17% and -1.70%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CalAmp (CAMP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CalAmp (CAMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for December 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Here's What Will Shape Medtronic's (MDT) Fate in Q2 Earnings
by Zacks Equity Research
Medtronic (MDT) is expected to maintain a decent market share in the core pacing banking, backed by the continued rollout of Micra Transcatheter Pacing System.
Will Product Innovations Aid Canopy Growth (CGC) in Q2?
by Zacks Equity Research
Canopy Growth (CGC) is expected to benefit from a solid top-line contribution in the Canadian medical cannabis market.
CalAmp (CAMP) Catches Eye: Stock Jumps 7.5%
by Zacks Equity Research
CalAmp (CAMP) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
CalAmp (CAMP) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CalAmp (CAMP) delivered earnings and revenue surprises of 10.71% and 0.78%, respectively, for the quarter ended August 2018. Do the numbers hold clues to what lies ahead for the stock?
CalAmp (CAMP) Q2 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
CalAmp (CAMP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why CalAmp (CAMP) Could Beat Earnings Estimates Again
by Zacks Equity Research
CalAmp (CAMP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
New Strong Sell Stocks for January 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for January 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for December 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
CalAmp Corp (CAMP) Worth a Look: Stock Adds 6% in Session
by Zacks Equity Research
CalAmp Corp. (CAMP) shares rose over 6% in the last trading session.
CalAmp (CAMP) Catches Eye: Stock Adds 13.3% in Session
by Zacks Equity Research
CalAmp Corp. (CAMP) moved big last session, as its shares jumped over 13% on the day.
Mobileye Continues to Face Headwinds: Should You Offload?
by Zacks Equity Research
Mobileye N.V. (MBLY) seems to be one such stock, which investors need to dump for now if they are looking to avoid long-term losses.
Should Value Investors Consider CalAmp Corp. Stock?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.